BioEridan Showcased Underwater Research Breakthroughs
The biotech firm debuted a new documentary highlighting its unique deep-sea hydroponic farming initiatives.
Updated on Sept. 21, 2026 in Biotech
Live Poll
Do you support prioritizing investment in biotechnology research focused on human longevity and healthy ageing?
BioEridan premiered its documentary, Science Beneath the Surface, in Belgrade and Cambridge this September. The film showcases the company's underwater Aquafarms, which operate 13 metres below sea level to advance longevity research.
Why it matters
The company aims to revolutionize healthy ageing by developing unique bioactive ingredients within controlled deep-sea environments. This initiative seeks to position Serbia as a central hub for global biotechnology and longevity science.
BioEridan operates Aquafarms at a depth of 13 metres beneath the sea. These facilities utilize controlled hydroponic systems designed to cultivate plant matter for specialized biotechnology research.
The players
BioEridan
This biotechnology company focuses on longevity science and operates innovative underwater hydroponic farms.
TS Ventures Fund
Established in 2021, this corporate venture capital fund holds €25 million in total capital.
The details
The firm is leveraging these pressurized underwater environments to study telomeres and cultivate plants for potential longevity products. This research was presented to international stakeholders during the UK-Serbia Health, Digital Transformation & Innovation roundtable.
Timeline
TS Ventures Fund was founded in 2021.
The documentary premiered in Belgrade on September 15, 2026.
The film screened at the University of Cambridge on September 16, 2026.
The Big Picture
This story follows a pattern set by the UK-Serbia Health, Digital Transformation & Innovation roundtable in fostering cross-border partnerships.
The firm is currently in the development phase for a bioactive ingredient intended for future consumer products. While these technologies are currently in research, they could eventually lead to new longevity-focused supplements or health goods for the public.
The takeaway
The use of deep-sea environments for hydroponics represents a shift toward extreme-condition biotechnology in search of health breakthroughs. Investors and researchers are now watching to see if these underwater methods can scale to produce viable market-ready ingredients.
Further reading
Learn more about the latest innovations in the Biotech sector.
More information
Read the View the full press release for additional project details.
Live Poll
Do you support prioritizing investment in biotechnology research focused on human longevity and healthy ageing?
